Skip Navigation


JAC Advance Access originally published online on May 23, 2005
Journal of Antimicrobial Chemotherapy 2005 56(1):253-254; doi:10.1093/jac/dki174
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/1/253    most recent
dki174v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Majoros, L.
Right arrow Articles by Szabó, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majoros, L.
Right arrow Articles by Szabó, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Correspondence

Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates

L. Majoros*, G. Kardos, P. Feiszt and B. Szabó

Department of Medical Microbiology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

* Corresponding author. Tel: +52-411-717/4501; Fax: +52-414-948; E-mail: major@jaguar.dote.hu

Keywords: minimal fungicidal concentration , Etest , Fungitest

The first 10% of the full text of this article appears below.

Sir,

Candida inconspicua, similarly to Candida krusei, possesses primary decreased susceptibility to fluconazole.1 During the past few years, the frequency of isolation of C. inconspicua has increased in our laboratory.2 Optimal treatment of C. inconspicua infections is not established, but in the reported cases amphotericin B was generally found effective.1

The aim of our study was to determine the MICs and minimal fungicidal concentrations (MFCs) of amphotericin B and flucytosine against clinical isolates of C. inconspicua.

We isolated 57 C. . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
M. A. Pfaller and D. J. Diekema
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Clin. Microbiol. Rev., January 1, 2007; 20(1): 133 - 163.
[Abstract] [Full Text] [PDF]